OSL oncosil medical ltd

Ann: Appendix 4E and Annual Report, page-4

  1. 659 Posts.
    lightbulb Created with Sketch. 260
    It’s quite shocking isn’t it?
    * 21 times Covid mentions of Covid in the annual report
    * plenty of hiring, mostly ex /redundant SRX people it seems , what’s the different between chief medical officer and global director clinical research? Why need both?
    * new marketing director it says. What happened to old one? His photos is gone from website.
    * key highlight moving the “global headquarters “ basically I think that’s one part of north Sydney to another part of nth syd.
    * pay ex CEO >530K in the 5 months to termination
    * notice use of the word “introduce “ Oncosil in the London clinic. No actual use though ?
    * bile duct US pushing one year late
    * no final results from pancor trial still!

    it’s no just bad luck or Covid for this being 5c.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.01
Change
-0.025(2.43%)
Mkt cap ! $14.29M
Open High Low Value Volume
$1.04 $1.05 $1.00 $41.05K 40.86K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.05 1249 1
View Market Depth
Last trade - 15.47pm 20/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.